Levomycetin-lekko eye drops 0.25% 10ml
Condition: New product
991 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Chloramphenicol
Release form
Drops
Composition
On 1 ml: chloramphenicol 2.5 mg. Excipients: boric acid.
Pharmacological effect
Levomycetin is a broad-spectrum antibiotic; it is effective against many gram-positive cocci (gonococci and meningococci), various bacteria (intestinal and hemophilus bacilli, salmonella, shigella, klebsiella, serration, iris, protei), rickettsia, spirochetes and some major viruses. The drug is active against strains resistant to penicillin, streptomycin, sulfonamides. It is weakly active against acid-resistant bacteria, Pseudomonas aeruginosa, clostridia and protozoa. It acts bacteriostatic. The mechanism of antibacterial action is associated with impaired protein synthesis of microorganisms. Drug resistance to the drug develops relatively slowly, while, as a rule, cross-resistance to other chemotherapeutic agents does not occur.
Pharmacokinetics
Therapeutic concentration of chloramphenicol when applied topically is created in the cornea, aqueous humor, iris, vitreous body; the drug does not penetrate into the lens. It is mainly excreted in the urine in the form of inactive metabolites
Indications
Prevention and treatment of infectious eye diseases: - conjunctivitis; - blepharitis; - keratitis
Contraindications
- oppression of blood formation; - skin diseases (psoriasis, eczema, fungal diseases); - pregnancy; - newborns; - individual intolerance to the drug.
Use during pregnancy and lactation
Contraindicated in pregnancy.
Dosage and administration
The drug is instilled into the conjunctival sac 1 drop 3-4 times / day. If the patient uses the drug at its discretion, it is not recommended to use it for more than three days without consulting a doctor.
Side effects
Allergic reactions may develop.
Overdose
When using eye drops in recommended doses, overdose is unlikely.
Interaction with other drugs
To prevent the strengthening of the inhibitory effect on blood formation, concurrent use with sulfa drugs is not recommended.